Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Hereditary diffuse gastric cancer: association with lobular breast cancer Schrader KA; Masciari S; Boyd N; Wiyrick S; Kaurah P; Senz J; Burke W; Lynch HT; Garber JE; Huntsman DGFam Cancer 2008[]; 7 (1): 73-82Hereditary diffuse gastric cancer (HDGC) has been shown to be caused by germline mutations in the gene CDH1 located at 16q22.1, which encodes the cell-cell adhesion molecule, E-cadherin. Not only does loss of expression of E-cadherin account for the morphologic differences between intestinal and diffuse gastric cancer (DGC) variants, but it also appears to lead to distinct cellular features which appear to be common amongst related cancers that have been seen in the syndrome. As in most hereditary cancer syndromes, multiple organ sites may be commonly affected by cancer, in HDGC, lobular carcinoma of the breast (LBC) and possibly other organ sites have been shown to be associated with the familial cancer syndrome. Given the complexity of HDGC, not only with regard to the management of the DGC risk, but also with regard to the risk for other related cancers, such as LBC, a multi-disciplinary approach is needed for the management of individuals with known CDH1 mutations.|*Genetic Predisposition to Disease[MESH]|*Germ-Line Mutation[MESH]|Antigens, CD[MESH]|Breast Neoplasms/epidemiology/*genetics/prevention & control[MESH]|Cadherins/*metabolism[MESH]|Carcinoma, Lobular/epidemiology/*genetics/prevention & control[MESH]|Female[MESH]|Gastrectomy[MESH]|Gene Expression Regulation, Neoplastic/genetics[MESH]|Genetic Counseling[MESH]|Humans[MESH]|Mass Screening[MESH]|Middle Aged[MESH]|Neoplasms, Multiple Primary/epidemiology/*genetics/prevention & control[MESH]|Risk[MESH]|Stomach Neoplasms/epidemiology/*genetics/prevention & control[MESH]|Syndrome[MESH] |